ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RKV Rakovina Therapeutics Inc

0.09
0.005 (5.88%)
May 03 2024 - Closed
Delayed by 15 minutes

Rakovina Therapeutics Financial Summary

The current RKV market cap is 6.28M. The company's latest EPS is CAD -0.0400 and P/E is -5.00.

Year End December 30 2022 202020212022
CAD ($)CAD ($)CAD ($)
Total Revenue 000
Operating Income -145k-2.06M-2.4M
Net Income -191k-5.52M-2.79M
Year End December 30 2022 202020212022
CAD ($)CAD ($)CAD ($)
Total Assets 813k8.66M6.12M
Total Liabilities 42k114k107k
Total Equity 771k8.54M6.01M

Cash Flow

Year End December 30 2022 202020212022
CAD ($)CAD ($)CAD ($)
Operating -69k-2.31M-1.92M
Investing 6k800k N/A
Financing 397k4.32M2k
Market Cap 6.28M
Price to Earnings Ratio -5.00
Price to Sales Ratio 0
Price to Cash Ratio 15.63
Price to Book Ratio 2.32
Dividend Yield -

Share Statistics

Shares Outstanding 69.83M
Average Volume (1 week) 44.25k
Average Volume (1 Month) 77.9k
52 Week Change -33.33%
52 Week High 0.15
52 Week Low 0.005
Spread (Intraday) 0.01 (5.56%)

Company Info

Company Name Rakovina Therapeutics Inc
Address 105, 1008 beach avenue
vancouver, british columbia V6E 1T7
Website https://www.rakovinatherapeutics.com
Industry unit inv tr, closed-end mgmt (6726)

Your Recent History

Delayed Upgrade Clock